MN Quraishi, M Widlak, N Bhala… - Alimentary …, 2017 - Wiley Online Library
Background Clostridium difficile infection (CDI) is the commonest nosocomial cause of diarrhoea. Faecal microbiota transplantation (FMT) is an approved treatment for recurrent or …
BC Wilson, T Vatanen, WS Cutfield… - Frontiers in cellular and …, 2019 - frontiersin.org
Fecal microbiota transplantation (FMT) has become a highly effective bacteriotherapy for recurrent Clostridium difficile infection. Meanwhile the efficacy of FMT for treating chronic …
Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing globally in recent years, particularly as a result of randomised studies in which it …
The community of microorganisms within the human gut (or microbiota) is critical to health and functions with a level of complexity comparable to that of an organ system. Alterations of …
D Drekonja, J Reich, S Gezahegn, N Greer… - Annals of internal …, 2015 - acpjournals.org
Background: The role of fecal microbiota transplantation (FMT) for Clostridium difficile infection (CDI) is not well-known. Purpose: To assess the efficacy, comparative …
2014-04-08 Assigned to Seres Health, Inc. reassignment Seres Health, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AFEYAN …
G McKenzie, MJL McKenzie, DN Cook, M Vulic… - US Patent …, 2015 - Google Patents
US9011834B1 - Compositions and methods - Google Patents US9011834B1 - Compositions and methods - Google Patents Compositions and methods Download PDF Info Publication …
US8906668B2 - Synergistic bacterial compositions and methods of production and use thereof - Google Patents US8906668B2 - Synergistic bacterial compositions and methods …
S Caballero, EG Pamer - Annual review of immunology, 2015 - annualreviews.org
The diverse microbial populations constituting the intestinal microbiota promote immune development and differentiation, but because of their complex metabolic requirements and …